277 filings
Page 3 of 14
8-K
8qtbp
3 Oct 18
Entry into a Material Definitive Agreement
8:00am
8-K
d7pp386y2 rs
26 Sep 18
Unregistered Sales of Equity Securities
12:00am
8-K
wx4bapz lgfj
20 Sep 18
ReShape Lifesciences Announces Proposed Public Offering
9:00am
8-K
bv9gq4w ysyootz5k7p
14 Sep 18
ReShape Lifesciences Announces Proposed Public Offering
12:00am
8-K
oojnsdz13
11 Sep 18
Departure of Directors or Certain Officers
12:00am
8-K
xom14mtwynq37
28 Aug 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
cpm kvuxqs
14 Aug 18
ReShape Lifesciences Announces Second Quarter 2018 Financial Results
4:06pm
8-K
6ya xkigmdv4wvs4t
13 Aug 18
Termination of a Material Definitive Agreement
8:00am
8-K
p8a8 hrl8fjrr9
2 Aug 18
ReShape Lifesciences Announces Registered Direct Offering
4:09pm
8-K
9l63k1kls
13 Jul 18
ReShape Lifesciences Announces $2.7 Million Registered Direct Offering Priced At-the-Market
4:16am
8-K
vfgsu
21 Jun 18
ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-the-Market
8:33am
8-K
nhnnh2p3
8 Jun 18
Departure of Directors or Certain Officers
5:14pm
8-K
ld8cox0 82c
8 Jun 18
ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-the-Market
8:34am
8-K
mmmbfw8qovgz5v3
1 Jun 18
Amendments to Articles of Incorporation or Bylaws
4:09pm
8-K
ju09kfrr o9b0
25 May 18
Entry into a Material Definitive Agreement
9:15am
8-K
clhpvo
18 May 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
it3wfajv
14 May 18
ReShape Lifesciences Announces Record Revenue for First Quarter 2018
4:07pm
8-K
094f wjc755g
24 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
2ur vh7oa
3 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
kaut lfms1y
2 Apr 18
ReShape Lifesciences Announces Fourth Quarter and Year End 2017 Financial Results
12:00am